Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo

• Egile Nagusiak: Zhao YY (Egilea), Tian Y (Egilea), Zhang J (Egilea), Xu F (Egilea), Yang YP (Egilea), Huang Y (Egilea), Zhao HY (Egilea), Zhang JW (Egilea), Xue C (Egilea), Lam MH (Egilea), Yan L (Egilea), Hu ZH (Egilea), Dinglin XX (Egilea), Zhang L (Egilea)
• Formatua: Liburua
• Argitaratua: Dove Medical Press, 2014-10-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Yuan-Yuan Zhao,1,* Ying Tian,1,* Jing Zhang,2,* Fei Xu,1 Yun-Peng Yang,1 Yan Huang,1 Hong-Yun Zhao,3 Jian-Wei Zhang,4 Cong Xue,1 Michael H Lam,5 Li Yan,5 Zhi-Huang Hu,1 Xiao-Xiao Dinglin,6 Li Zhang1,3 1Department of Medical Oncology, Sun Yat-Sen University Cancer Center, S...